2016-12-15,Medgenics, Inc. Announces Name Change To Aevi Genomic Medicine, Inc.
2016-11-04,Oversold Conditions For Medgenics (MDGN)
2016-10-29,Medgenics Presents New Data Showing Prevalence Of Genetic Mutations In Pediatric Populations With Attention Deficit Hyperactivity Disorder
2016-10-26,Short Interest In Medgenics Moves 100% Lower
2016-09-09,Medgenics Enters Oversold Territory (MDGN)
2016-08-16,Commit To Buy Medgenics At $5, Earn 15.4% Annualized Using Options
2016-03-20,8 Biotech Stocks Under $10 Making Big Moves Higher
2016-01-26,Medgenics To Participate In The 2016 Canaccord Genuity Rare Disease, BioPharma One-On-One Day
2016-01-07,RSI Alert: Medgenics (MDGN) Now Oversold
2016-01-07,MDGN: Insiders vs. Shorts
2016-01-06,Medgenics Licenses Novel GeneRide Gene Therapy Technology From Stanford University
2015-12-22,Medgenics Announces Annual Renewal Of Rare And Orphan Disease Research Collaboration With The Children's Hospital Of Philadelphia
2015-12-16,Medgenics Announces Beta Thalassemia Research Program
2015-11-25,Medgenics To Present At 27th Annual Piper Jaffray Healthcare Conference
2015-10-22,Medgenics Reports Third Quarter 2015 Financial Results
2015-10-15,Medgenics To Host Conference Call To Announce Third Quarter 2015 Results On October 22, 2015
2015-10-14,5 Stocks Insiders Love Right Now
2015-10-13,Medgenics Announces Key Appointments
2015-10-12,Medgenics Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Option To Purchase Additional Shares Of Common Stock
2015-10-09,MDGN: Insiders vs. Shorts
2015-10-05,Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector
2015-10-01,Medgenics Prices Public Offering Of Common Stock
2015-09-30,Medgenics Announces Public Offering Of Common Stock
2015-09-09,Medgenics Acquires Phase 2-Ready CNS Program: NFC-1
2015-09-03,Medgenics To Present At 22nd Annual NewsMakers In The Biotech Industry Conference
2015-08-27,Short Interest Increases 15% For MDGN
2015-08-10,Medgenics Reports Second Quarter 2015 Financial Results
2015-07-28,Short Interest Expands By 61.4% For MDGN
2015-07-15,Medgenics Announces First Patient Enrolled In U.S.-Based Phase 2 Clinical Trial Of TARGT-EPO For Treatment Of Anemia In ESRD Patients Undergoing Peritoneal Dialysis
2015-06-29,Medgenics Added To RUSSELL 3000(R) And Global Indexes
2015-06-22,Medgenics Becomes Oversold (MDGN)
2015-06-17,Medgenics To Present At JMP Securities Life Sciences Conference 2015
2015-06-11,Medgenics Awarded $3.4 Million Grant From The Israeli Office Of The Chief Scientist
2015-06-10,Medgenics Announces Appointment Of Barbara Duncan To Board Of Directors
2015-06-04,Medgenics To Present Clinical Data At The 20th Congress Of The European Hematology Association
2015-05-07,Medgenics Announces Participation In Upcoming Conferences
2015-04-17,Medgenics Reports First Quarter 2015 Financial Results
2015-04-02,Medgenics To Host Conference Call To Announce First Quarter 2015 Results On April 17, 2015
2015-03-02,Medgenics To Present At Upcoming Investor Conferences
2015-02-25,5 Stocks Insiders Love Right Now: GE, Mondelez and More
2015-02-13,Medgenics Reports Fourth Quarter And Full Year 2014 Financial Results
2015-01-30,Medgenics To Host Conference Call To Announce Fourth Quarter And Full Year 2014 Results On February 13, 2015
2015-01-08,Medgenics To Present At Biotech Showcase 2015 Conference
2014-11-25,Medgenics To Present At 26th Annual Piper Jaffray Healthcare Conference
2014-11-25,Medgenics Prices Public Offering Of Common Stock
2014-11-24,Medgenics Announces Public Offering Of Common Stock
2014-11-12,Medgenics Announces Rare & Orphan Disease Research Collaboration With The Children's Hospital Of Philadelphia
2014-10-15,Medgenics Reports Positive Initial Clinical Data And Third Quarter Financial Results
2014-10-08,Medgenics To Host Conference Call To Announce Third Quarter 2014 Results And Provide Initial Clinical Data On MDGN-201 On October 15, 2014
2014-10-07,Medgenics To Present Initial Clinical Data From MDGN-201 Study At European Society Of Gene And Cell Therapy Congress
2014-09-24,Medgenics To Announce Third Quarter 2014 Results And Provide Initial Clinical Data On MDGN-201 (EPODURE(TM)) Trial On October 15, 2014
2014-09-10,Medgenics Announces The Appointment Of Scott Applebaum As Chief Legal Officer
2014-08-28,Medgenics Enters Oversold Territory (MDGN)
2014-07-17,Medgenics Becomes Oversold (MDGN)
2014-07-16,Medgenics Reports Second Quarter Financial Results
2014-06-18,Medgenics Announces Global Head, Research And Development, Garry Neil, M.D. Receives FDA Commissioner's Special Citation Award
2014-06-16,Medgenics To Present At Two Upcoming Healthcare Investor Conferences
2014-06-05,Medgenics Announces First Patient Implanted In Phase 1/2 Clinical Trial Of MDGN-201 (EPODURE)
2014-05-08,Medgenics Reports First Quarter Financial Results
2014-04-30,Medgenics Becomes Oversold (MDGN)
2014-04-15,Medgenics Awarded $2.2 Million Grant From The Israeli Office Of The Chief Scientist
2014-04-09,Medgenics Announces Results Of 2014 Annual Meeting Of Stockholders
2014-04-03,Medgenics Becomes Oversold (MDGN)
2014-03-14,Faruqi & Faruqi, LLP Launches An Investigation Against Medgenics, Inc. (MDGN) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
2014-03-05,Medgenics, Inc. To Present At The 26th Annual ROTH Capital Growth Conference
2014-02-20,Medgenics Reports 2013 Financial Results
2014-01-07,Medgenics Issues Stock Options And Restricted Shares To Non-Executive Directors
2013-12-24,Medgenics Announces Director Enters Into Stock Trading Plan And Change Of Adviser
2013-12-18,Medgenics Reports Open Market Purchase Of Common Stock By Director
2013-12-16,Medgenics Reports Open Market Purchase Of Common Stock By Chairman Of The Board
2013-12-13,Medgenics Becomes Oversold (MDGN)
2013-12-04,Medgenics To Present At The Oppenheimer 24th Annual Healthcare Conference
2013-12-04,Top Insider Trades: CYTR TROX KTOS MDGN
2013-12-04,Medgenics Reports Sale Of Common Stock By Director
2013-12-04,3 Stocks Under $10 in Breakout Territory
2013-12-03,Medgenics Reports Open Market Purchase Of Common Stock By Chairman Of The Board
2013-11-07,Medgenics Reports Third Quarter Financial Results
2013-11-04,Medgenics To Host Business Update Conference Call On Friday, November 8th At 8:30 A.m. Eastern Time
2013-10-27,Medgenics Reports Positive Data With Second-Generation Viral Vectors At European Society Of Gene And Cell Therapy Congress
2013-10-23,Medgenics To Present Poster At European Society Of Gene And Cell Therapy Congress To Highlight Results From Second-Generation Viral Vector
2013-10-17,Medgenics Appoints Biopharmaceutical Industry Veteran Bill Gantz To Its Board Of Directors
2013-09-20,Top Insider Trades: PCI BTH HALL MDGN
2013-09-16,Medgenics Announces New Executive Leadership Team
2013-08-06,Medgenics Reports Second Quarter Financial Results
2013-07-09,Medgenics Awarded $1.9 Million Grant From The Israeli Office Of The Chief Scientist
2013-07-08,Medgenics To Present At The 8th Annual JMP Securities Healthcare Conference
2013-03-26,Medgenics Announces Exercise By Underwriters Of Over-Allotment Option
2013-03-15,Medgenics To Present At The 25th Annual Roth Conference
2013-03-14,Medgenics Reports 2012 Financial Results
2013-03-12,Medgenics Appoints Former Chairman And CEO Of UBS Financial Services Joseph J. Grano, Jr. To Board Of Directors
2013-02-21,5 Stocks Under $10 Triggering Breakouts
2013-02-14,Medgenics Announces Closing Of Public Offering Of Common Stock And Warrants
2013-02-11,Fisking Ray Dirks on Medgenics and Shaming Seeking Alpha
2013-02-08,Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics
2013-02-08,Medgenics Prices Public Offering Of Common Stock And Warrants
2013-01-30,Medgenics Launches First Clinical Trial In Hepatitis To Use INFRADURE Tissue Treatment
2013-01-04,Medgenics, Inc. (the &#8220;Company&#8221;) Issue Of Options And Restricted Shares To Directors And Officers
2012-12-06,Medgenics Key Patent Claims Allowed In Japan Protecting Core Technology To Be Used In Hepatitis Treatment
2012-11-28,Renowned Experts Affirm Potential Of Medgenics&#8217; INFRADURE Technology For The Treatment Of Hepatitis B And D
2012-11-21,Medgenics Granted U.S. Patent For Core Technology Used In Sustained Delivery Of Erythropoietin, Aimed At Multi-Billion Dollar Anemia Market
2012-11-14,Medgenics Reports Third Quarter 2012 Financial Results
2012-11-02,Medgenics Presents Preliminary Data From Phase IIa Study With EPODURE To Treat Anemia In Dialysis Patients At Kidney Week 2012
2012-10-25,5 Stocks Under $10 Set to Soar
2012-10-23,Medgenics Announces EPODURE To Be Presented In Poster Session At The American Society Of Nephrology&#8217;s Kidney Week 2012
2012-10-16,Medgenics Announces Filing Of Shelf Registration
2012-08-29,Medgenics&#8217; Novel Tissue Implant Approved For Two Hepatitis C Clinical Trials In Israel
2012-08-28,Medgenics Mourns The Loss Of Board Member Gary Brukardt
2012-08-14,Medgenics Appoints Dr. Marvin Garovoy As Chief Medical Officer
2012-08-13,Medgenics Announces Second Quarter 2012 Financial Results
2012-07-23,Medgenics Announces Registration Of Shares To Be Issued Upon Exercises Of Warrants Listed On NYSE MKT
2012-07-17,First Subjects Enrolled In Phase IIa Clinical Trial Of EPODURE Biopumps To Treat Anemia In Patients With End-Stage Renal Disease On Dialysis
2012-07-02,Medgenics Appoints Former Celgene CEO Dr. Sol Barer As Chairman Of The Board
2012-06-20,Medgenics Receives Orphan Drug Designation From FDA For INFRADURE Biopump To Treat Hepatitis D
2012-06-19,Medgenics, Inc. Raises $9.5 Million In Private Placement
2012-06-07,Medgenics Initiates U.S. Biopump Processing Site
2012-05-18,Medgenics To Present At The 11th Annual ILSI BIOMED 2012
2012-05-17,Medgenics Receives FDA Clearance To Commence Phase IIb Trial Of EPODURE For Sustained Anemia Treatment In Dialysis Patients
2012-04-26,Medgenics Comments On Market Trading Activity
2012-04-17,Medgenics Files IND Application For EPODURE Biopump Phase IIb Anemia Study In Dialysis Patients
2012-04-05,Medgenics Announces Results Of 2012 Annual Meeting Of Stockholders
2012-03-26,Medgenics Reports Positive Meeting With NIH Recombinant DNA Advisory Committee
2012-03-23,Medgenics Cleared To Initiate Phase IIa Anemia Study Of EPODURE Biopump In Dialysis Patients In Israel
2012-03-21,Medgenics To Present At The Maxim Group Growth Conference
2012-03-13,Medgenics Announces Participation In Roth Conference And Other Matters
2012-03-06,Medgenics Announces 2011 Financial Results
2012-02-15,Medgenics To Present At LHA Life Sciences &amp; Medical Technologies Virtual Conference
2012-01-25,Medgenics Sets Record Date For 2012 Annual Meeting Of Stockholders
2012-01-24,Medgenics Adds Two Key Opinion Leaders To Strategic Advisory Board
2012-01-20,Medgenics' Receives Allowance For Key European Patent
2012-01-09,Medgenics, Inc. Announces Issue Of Options And Restricted Shares To Directors And Officers
2011-11-28,Medgenics To Present At The Piper Jaffray 23rd Annual Healthcare Conference
2011-11-15,Medgenics Presents Expanded Results Of Phase I/II Study Of EPODURE Biopump For The Treatment Of Anemia At&#160;the American Society Of Nephrology&#8217;s Kidney Week 2011
2011-11-10,Medgenics Reports Third Quarter Financial Results
2011-11-09,Medgenics Provides Clinical And Regulatory Update
2011-10-14,Update On Development Of Factor VIII Biopump
2011-09-09,Medgenics To Present At Rodman &amp; Renshaw 13th Annual Global Investment Conference
2011-09-09,Medgenics Announces Actions Taken At Annual Meeting Of Stockholders
2011-08-30,Medgenics Announces Annual Meeting Of Stockholders
2011-08-12,Medgenics Reports Second Quarter Financial Results
2011-08-10,Medgenics Awarded Grant From The Israeli Office Of The Chief Scientist
2011-07-06,Medgenics Extends Collaboration With Baxter On Development Of Factor VIII Biopump
2011-07-05,Medgenics Names Clarence &#8220;Butch&#8221; Dellio As Chief Operating Officer
2011-06-08,Leading Biotechnology Entrepreneur And Investor Isaac Blech Joins Medgenics Board Of Directors
2011-05-19,Medgenics To Present At The 10th Annual ILSI Biomed 2011 Conference
2011-05-12,Medgenics Announces First Quarter Financial Results
,
